Allergen-specific immunotherapy practices and course of coronavirus disease 2019 (COVID-19) in patients during COVID-19.

Erkoc M., Ozturk B. O., Mungan D., Oztuna D., Bavbek S., Demirel Y. S., ...Daha Fazla

Asia Pacific allergy, cilt.12, sa.1, 2022 (Hakemli Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 12 Sayı: 1
  • Basım Tarihi: 2022
  • Doi Numarası: 10.5415/apallergy.2022.12.e6
  • Dergi Adı: Asia Pacific allergy
  • Anahtar Kelimeler: Allergen-specific immunotherapy, Subcutaneous immunotherapy, Venom immunotherapy, Coronavirus disease 2019, Compliance, Adults, IMMUNOLOGY, ASTHMA
  • Ankara Üniversitesi Adresli: Evet

Özet

Background: Allergen-specific immunotherapy (AIT) is accepted as the only diseasemodifying therapy for IgE-mediated allergic airway diseases and hymenoptera venom allergy. AIT requires repeated contact between patient and physician or nurse in the hospital. Because it is a long-term treatment, compliance is essential issue to obtain maximal efficacy. Coronavirus disease 2019 (COVID-19) pandemic reshaped doctor-patient interaction and pattern of hospital admissions.